Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Cardiovascular Drugs and Therapy|April 10, 2010
Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct sizeYumei Ye, Kyle T Keyes, Chong F Zhang, et al.
Journal of Orthopaedics|December 5, 2022
Hamstring injuries in the national football league: An epidemiological studyDylan Luxenburg, Nathan A Wasserman, Joseph S Geller, et al.
American Journal of Physiology. Heart and Circulatory Physiology|April 11, 2006
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactionsYumei Ye, Yu Lin, Shaul Atar, et al.
The Journal of Biological Chemistry|February 22, 2005
Redirection of eicosanoid metabolism in mPGES-1-deficient macrophagesCatherine E Trebino, James D Eskra, Timothy S Wachtmann, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 30, 2012
Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetesYumei Ye, Jinqiao Qian, Alexander C Castillo, et al.
Journal of Strength and Conditioning Research|November 30, 2021
Effect of Passing Plays on Injury Rates in the National Football LeagueJonathan Burke, Joseph S Geller, Jose R Perez, et al.
Cardiovascular Drugs and Therapy|September 1, 2012
Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitusYochai Birnbaum, Alexander C Castillo, Jinqiao Qian, et al.
Orthopedic Reviews|September 28, 2022
Characteristics and Trends of the Most Cited Clinical Orthopaedics and Related Research ArticlesJuan J Lizardi, David S Constantinescu, Jonathan R Weinerman, et al.
Pageof 6